&w=3840&q=100)
Smallcap stock zooms 107% in 3 months, nears record high; here's why
In the past three months, the stock price of the small-cap castings and forgings company has more than doubled or up 107 per cent, from a level of ₹86.36.
Share price of Nelcast has surpassed its previous high of ₹170.85 touched on July 24, 2025. It is quoting close to its record high level of ₹194.50 hit on November 9, 2023.
At 10:58 AM, Nelcast was quoting 11 per cent higher at ₹174, as compared to a 0.02 per cent decline in the BSE Sensex. The average trading volumes on the counter jumped over six-fold, with a combined 5.41 million shares representing 6.2 per cent of the total equity of Nelcast changing hands on the NSE and BSE. Track LIVE Stock Market Updates
Nelcast Q1 results
In the April to June 2025 quarter (Q1FY26), Nelcast reported 57.2 per cent year-on-year (Y-o-Y) growth in consolidated profit after tax (PAT) of ₹12.5 crore. The company had posted PAT of ₹8.0 crore in Q1FY25. Total revenue increased 11.1 per cent Y-o-Y at ₹336.0 crore.
Earnings before interest, taxes, depreciation, and amortisation (Ebitda) jumped 44.3 per cent Y-o-Y at ₹32.4 crore, margin improved 222 bps at 9.6 per cent from 7.4 per cent in the year-ago quarter.
The margins have strengthened significantly, with Ebitda per kg rising 24 per cent Y-o-Y to ₹14.7 per kg, reaffirming guidance to reach ₹15 per kg by the end of FY26. While FY25 was a year of consolidation, FY26 is about building a strong foundation for the future, the company said.
Nelcast FY26 Outlook
The tractor segment saw robust growth, supported by a favourable monsoon, while MHCV and other segments delivered steady performance. Despite early concerns around tariff-related uncertainties in key export markets, the management believes the impact will be limited and manageable.
Exports grew by 17 per cent Y-o-Y to ₹115 crore, and the management remains optimistic about long-term opportunities, especially with the UK FTA expected to shift sourcing preferences to India.
The management said the company's strategic focus on new product development and capacity optimisation in FY26, laying the groundwork for accelerated growth over the next two years. The company reaffirmed Ebitda per kg guidance of ₹15 per kg for FY26, driven by margin expansion and operational efficiencies.
Several other new product samples are also in progress, setting the stage for meaningful growth in FY27 and FY28.
Meanwhile, Nelcast enjoys the confidence of its valued customers for providing quality products. Therefore, as newer and more advanced castings are developed, the company has an edge over the competition due to its diverse capabilities. It has made significant investments to increase capacity and is poised to take advantage of the growth from both the domestic automotive industry and the global market, Nelcast said in its FY25 annual report.
About Nelcast
Nelcast manufactures grey and ductile castings for the M&HCV and tractor industry segments. Around 30-35 per cent of its overall revenues are also generated from export markets. Key products supplied to its M&HCV clients include differential carriers, differential cases, bogie suspension brackets, and conventional brackets, among others.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Indian Express
an hour ago
- Indian Express
Private promoter ownership dips to 8-year low in June 2025 quarter
Private promoters holding in the domestic capital market declined to an eight-year low of 40.58 per cent during the quarter ended June 30, down from 40.81 per cent as on March 31, 2025. In the April-June 2025 quarter, promoters sold Rs 54,732 crore worth of their holding on a net basis. In rupee value terms, private promoter holding stood at Rs 184.61 lakh crore as on June 30, 2025, according to a report by PRIME Database Group. This analysis is based on shareholding patterns filed by 2,086 of the total 2,131 companies listed on NSE (main board) for the quarter ending June 30, 2025. 'While promoter buying is always a positive sign, promoter selling can be due to a wide variety of reasons such as promoters taking advantage of bullish markets to take money off the table, strategic reasons like debt reduction, legacy planning, philanthropy, investment in other ventures and meeting Minimum Public Shareholding (MPS) requirement as also for personal expenses,' said Pranav Haldea, managing director, PRIME Database Group. Besides, relatively lower promoter holding in some of the recent IPO companies and overall institutionalisation of market are also the other reasons behind decline in promoter shareholding. Some of the companies that saw the highest selling, on a net basis, by private promoters in the June 2025 quarter included Bharti Airtel (Rs 13,059 crore), Interglobe Aviation (Rs 11,863 crore), Vishal Mega Mart (Rs 11,215 crore), Samvardhana Motherson International Ltd (Rs 6,227 crore), and Bajaj Finserv Ltd. (Rs 5,725 crore). In the June 2025 quarter, domestic institutional investors (DIIs) continued their dominance in the stock market, the report showed. The share of domestic institutional investors (DIIs) touched an all-time high of 17.82 per cent as on June 30, 2025, up from 17.62 per cent as on March 31, 2025, following a net investment of Rs 1.68 lakh crore during the April-June period, the report said On the other hand, the share of foreign institutional investors (FIIs), declined further to a 13-year low of 17.04 per cent from 17.22 per cent during the previous quarter, despite a net inflow of Rs 38,674 crore (inflow of Rs 29,793 in secondary market and inflow of Rs 8,881 crore in primary market). The increase in DIIs' share was mainly on account of domestic mutual funds (MFs) that are flush with retail money coming through systematic investment plan (SIPs). They invested Rs 1.17 lakh crore on a net basis during the quarter. Mutual funds' share in NSE listed companies reached an all-time high of 10.56 per cent as on June 30, 2025 (up from 10.35 per cent). Besides, mutual fund players, the domestic insurance companies too invested Rs 8,076 crore on net basis during the quarter even though their overall share went down from 5.40 per cent to 5.30 per cent, the report said.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Chinese investor Ant Group may exit Paytm after offloading 5.84% stake
Ant Group is expected to offload its remaining 5.84% stake in Paytm worth $434 million, marking a potential exit from the fintech firm. The deal comes amid growing regulatory concerns Mumbai Chinese investor Ant Group is expected to exit fintech major Paytm by offloading its remaining 5.84% stake through block deals worth approximately $434 million, according to a report by Reuters. Ant is anticipated to sell the stake at a floor price of ₹1,020 per share. This represents a 5.4% discount to Paytm's closing price of ₹1,078.30 per share on August 4 on the Bombay Stock Exchange (BSE). Goldman Sachs India Securities and Citigroup Global Markets India are expected to lead the sale. In May, it sold about 4% of its total holding in Paytm operator One97 Communications. As of the March 2025 (Q4FY25) quarter, its stake in the company stood at 9.85%. In August 2023, it had offloaded a 10.3% stake in the company. Prior to that, the investor held a 23.79% stake in Paytm as of the June 2023 (Q1FY24) quarter, according to data from the BSE. The sale of the stake comes amid regulatory scrutiny regarding investments by Chinese-origin investors. The first quarter of 2025-26 (Q1FY26) turned profitable for One97 Communications, the parent company of fintech player Paytm, after a steep loss of ₹838.9 crore in Q1FY25. The net profit of ₹122.5 crore in Q1FY26 was largely driven by sharp cost controls. The fintech firm had posted a net loss of ₹539.8 crore in Q4FY25.
&w=3840&q=100)
Business Standard
an hour ago
- Business Standard
Aurobindo Pharma Q1 results: Profit drops 10% to ₹824 crore on US sales
Aurobindo Pharma on Monday reported a 10 per cent decline in its consolidated net profit to ₹824 crore for the June quarter, hit by dip in sales in the US and API business vertical. The Hyderabad-based drug maker posted a net profit of ₹918 crore for the April-June quarter of last fiscal. Revenue from operations increased to ₹7,868 crore for the June quarter as against ₹7,567 crore in the year-ago period, Aurobindo Pharma said in a regulatory filing. "We started the year steadily, with our European business maintaining strong growth momentum and our core US business showing resilience despite temporary challenges from destocking and seasonal dynamics," K Nithyananda Reddy, Vice-Chairman and Managing Director of the company said. The company's disciplined execution, operational initiatives, and recent US acquisition strengthens commercial footprint and accelerates growth potential, he added. The board of directors at its meeting held on Monday has approved the payment of interim dividend of 400% i.e ₹4.00 per equity share of ₹1. /- each on equity share capital of the company. The company has fixed August 8, 2025, as the record date for purpose of the payment of interim dividend. Shares of the company on Monday ended 1.04 per cent up at ₹1,090.90 apiece on BSE. (Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
